Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Evaluate the Effectiveness of Valsartan 320 mg in Combination With Lisinopril 20 mg Versus Monotherapy With Lisinopril 40 mg or Valsartan 320 mg in Hypertensive Patients With Microalbuminuria on the Reduction of Urinary Albumin Creatinine Ratio

NCT00171067 is registered in ClinicalTrials.gov with Novartis as lead sponsor.

NCT NCT00171067
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00171067 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Evaluate the Effectiveness of Valsartan 320 mg in Combination With Lisinopril 20 mg Versus Monotherapy With Lisinopril 40 mg or Valsartan 320 mg in Hypertensive Patients With Microalbuminuria on the Reduction of Urinary Albumin Creatinine Ratio
Lead sponsor
Novartis
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2004
Completion date
May 31, 2007
Enrollment
134 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension